The study enrolled 4128 patients 60 years and older with NYHA class II-IV symptoms and ejection fraction ≥45% who were hospitalized for heart failure during the last 6 months or had persistent ...
AFICAMTEN was found to be a safe and effective treatment for symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), ...
A recent study published in the Frontiers in Endocrinology journal showed that heart failure with preserved ejection fraction ...
Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...
SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback